Jul 19, 2014

Firm begins stem cell therapy trial for treatment of chronic heart failure

CardioCell has started the Phase IIa trial of its ischemia-tolerant mesenchymal stem cell therapy for patients with chronic heart failure tied to nonischemic cardiomyopathy. READ FULL ARTICLE